An overview of the NCCN and ASCO guidelines on cancer-associated venous thromboembolism

Research output: Contribution to journalArticle

Abstract

Venous thromboembolism (VTE) is a common complication of cancer and its treatment. The National Comprehensive Cancer Center Network (NCCN) and the American Society of Clinical Oncology (ASCO) have published evidence-based guidelines on the management of VTE in the cancer patient. This paper will review the literature basis and substance of the NCCN and ASCO guidelines. Topics include the prevention, diagnosis, and treatment of deep and superficial vein thrombosis, catheter-associated thrombosis, and pulmonary embolism. Management of recurrent thromboembolism and the use of anticoagulation to improve cancer survival as well as indications for thrombolytic therapy and vena cava filters are also reviewed.

Original languageEnglish (US)
Pages (from-to)41-52
Number of pages12
JournalCancer Investigation
Volume27
Issue numberSUPPL. 1
DOIs
StatePublished - Mar 1 2009

    Fingerprint

Keywords

  • ASCO
  • Cancer
  • NCCN
  • Prevention
  • Treatment
  • Venous thromboembolism

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this